In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lilly announces Guidant IPO for 20% of new company's stock

Executive Summary

Eli Lilly's device spin-off, Guidant Corp. (cardiac rhythm management, coronary artery disease intervention, minimally invasive surgery) has completed its IPO of 14.26 million shares at $14.50 per share, netting $192.5 million.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO
    • Spin-Off

Related Companies